CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes? Coronary flow velocity reserve predicts adverse prognosis in women with angina and noobstructive coronary artery disease: resultsfrom the iPOWER study 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA /ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Effect of Aspirin on All-Cause Mortality in the Healthy Elderly Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions

Review Article2016 Jul 25;9(14):1419-34.

JOURNAL:JACC Cardiovasc Interv. Article Link

Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials

Ferrante G, Rao SV, Valgimigli M et al. Keywords: bleeding; femoral access; percutaneous coronary intervention; radial access; vascular complications

FULL TEXT PDF